Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Chow

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Cardiology|December 17, 2009
Coexisting vasospastic angina and undiagnosed Brugada syndrome resulting in cardiac arrestVincent Chow, Isuru Ranasinghe, John Yiannikas
Australasian Journal of Ultrasound in Medicine|November 11, 2021
Early diagnosis of lymphoma utilising Doppler pulmonary artery flow imagingTonglin Su, Leonard Kritharides, Vincent Chow
Clinical Therapeutics|February 6, 2022
Establishing PK Equivalence Between Adalimumab and ABP 501 in the Presence of Antidrug Antibodies Using Population PK ModelingSameer Doshi, Hui Wang, Vincent Chow
The Medical Journal of Australia|February 3, 2017
Cardiovascular disease in patients with schizophreniaLeonard Kritharides, Vincent Chow, Tim Jr Lambert
Cancer Chemotherapy and Pharmacology|August 6, 2021
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjectsVladimir Hanes, Vincent Chow, Tina Stewart, et al.
Journal of Clinical Ultrasound : JCU|April 19, 2011
Thrombus in transit within a patent foramen ovale: an argument for consideration of prophylactic closure?Vincent Chow, William Wang, Michael Wilson, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2017
A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteersSriram Krishnaswami, Mary Boy, Vincent Chow, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjectsVladimir Hanes, Vincent Chow, Nan Zhang, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2018
A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjectsVladimir Hanes, Vincent Chow, Zhiying Pan, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology|December 17, 2009
Coexisting vasospastic angina and undiagnosed Brugada syndrome resulting in cardiac arrestVincent Chow, Isuru Ranasinghe, John Yiannikas
Australasian Journal of Ultrasound in Medicine|November 11, 2021
Early diagnosis of lymphoma utilising Doppler pulmonary artery flow imagingTonglin Su, Leonard Kritharides, Vincent Chow
Clinical Therapeutics|February 6, 2022
Establishing PK Equivalence Between Adalimumab and ABP 501 in the Presence of Antidrug Antibodies Using Population PK ModelingSameer Doshi, Hui Wang, Vincent Chow
The Medical Journal of Australia|February 3, 2017
Cardiovascular disease in patients with schizophreniaLeonard Kritharides, Vincent Chow, Tim Jr Lambert
Cancer Chemotherapy and Pharmacology|August 6, 2021
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjectsVladimir Hanes, Vincent Chow, Tina Stewart, et al.
Journal of Clinical Ultrasound : JCU|April 19, 2011
Thrombus in transit within a patent foramen ovale: an argument for consideration of prophylactic closure?Vincent Chow, William Wang, Michael Wilson, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2017
A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteersSriram Krishnaswami, Mary Boy, Vincent Chow, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjectsVladimir Hanes, Vincent Chow, Nan Zhang, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2018
A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjectsVladimir Hanes, Vincent Chow, Zhiying Pan, et al.
Pageof 11